search
Back to results

Safety of Skin Cleansing With Chlorhexidine in Preterm Low Birth Weight Infants

Primary Purpose

Neonatal Sepsis, Low Birth Weight

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Chlorhexidine
Normal saline
Sponsored by
All India Institute of Medical Sciences, New Delhi
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Neonatal Sepsis focused on measuring chlorhexidine, preterm, newborn, skin condition, temperature, skin flora

Eligibility Criteria

1 Hour - 3 Hours (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Preterm infants of 28 to 36 weeks' gestation
  • Birth weights between 1001 and 2000 g

Exclusion Criteria:

  • Infants with one minute Apgar score < 4
  • Hemodynamic instability
  • Congenital malformations
  • Generalized skin disorder and
  • Infants who need respiratory support (continuous positive airway pressure and/or intermittent mandatory ventilation) in the first 2-3 hours of life

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Experimental

    Placebo Comparator

    No Intervention

    Arm Label

    Chlorhexidine skin cleansing

    Saline skin cleansing

    No skin cleansing

    Arm Description

    Wiping the skin (except the face) once immediately after birth using baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)

    Wiping the skin (except the face) once immediately after birth using baby wipes containing normal saline

    No skin application

    Outcomes

    Primary Outcome Measures

    Median Skin Condition Score on the 9-point Skin Condition Grading Scale Adapted by Darmstadt From Lane et al
    The skin condition grading scale assesses the condition of the skin on the abdomen and dorsum of the hands/feet based on drying, erythema, crusting, oozing, etc. on a continuous scale from 1 (normal) to 9 (vesicles or pustules)
    Skin Temperature at 30 Min After Intervention
    Axillary skin temperature measured by a clinical thermometer kept in axilla for 3 minutes
    Number of Participants With Positive Skin Culture at Axilla
    Occurrence of any bacterial flora irrespective of the colony count in the skin swabs from axilla at 24 hrs after intervention

    Secondary Outcome Measures

    Incidence of Clinical and Culture Positive Sepsis
    Infants with symptoms and/or signs suggestive of sepsis and a positive blood culture (with known pathogens and coagulase negative staphylococcus) were diagnosed to have culture positive sepsis; Those with negative cultures but with positive sepsis screen were classified as having clinical sepsis

    Full Information

    First Posted
    April 20, 2009
    Last Updated
    March 19, 2018
    Sponsor
    All India Institute of Medical Sciences, New Delhi
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00947518
    Brief Title
    Safety of Skin Cleansing With Chlorhexidine in Preterm Low Birth Weight Infants
    Official Title
    Does Skin Cleansing With Chlorhexidine Affect Skin Condition, Temperature and Colonization in Hospitalized Preterm Low Birth Weight Infants?: A Randomized Clinical Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2009
    Overall Recruitment Status
    Completed
    Study Start Date
    August 2005 (undefined)
    Primary Completion Date
    February 2006 (Actual)
    Study Completion Date
    February 2006 (Actual)

    3. Sponsor/Collaborators

    Name of the Sponsor
    All India Institute of Medical Sciences, New Delhi

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to examine if single skin cleansing with 0.25% chlorhexidine affects skin condition, temperature, and bacterial colonization in stable preterm (28-36 weeks gestational age) low birth weight (1001-2000 g) infants admitted in a health facility.
    Detailed Description
    Infections are the leading cause of death in neonates admitted to hospital - studies from developing countries suggest that about 25-71% of deaths occurring in neonatal intensive care units are secondary to infections.Such high infection-related mortality mandates an urgent implementation of simple and effective measures to prevent the occurrence of infections in these units. The majority of neonatal infections occur in the first two weeks of life, when the epidermal barrier is immature and functionally compromised. Topical application of antiseptics until the skin matures could theoretically prevent skin colonization and reduce the incidence of systemic infections in neonates. Chlorhexidine, a broad-spectrum antiseptic used frequently for umbilical cord care in neonates, is now being evaluated for topical application to the skin. Hospital-based studies, involving predominantly term infants, have shown reductions in skin flora8 and a reduction in the incidence of sepsis following topical chlorhexidine application. In a community-based study in Nepal, a single skin cleansing with 0.25% chlorhexidine resulted in reduction in mortality among low birth weight infants; though the mechanism of the impact could not be determined, it was presumably due to increased susceptibility to transcutaneous sepsis in the low birth weight group. Since the risk of infection in neonates is inversely related to their gestation, it is essential to evaluate the effect and the mechanism of such intervention in preterm neonates. These infants are, however, more prone to develop skin reactions following use of topical antiseptics. Preterm infants are also more prone to develop hypothermia following bathing/cleansing with antiseptic solution(s). Since few studies have evaluated the effects of topical application of chlorhexidine in preterm infants admitted in a health care facility, we conducted the present study to examine if single skin cleansing with 0.25% chlorhexidine immediately after birth affects skin condition, temperature, and colonization in hospitalized preterm low birth weight infants.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Neonatal Sepsis, Low Birth Weight
    Keywords
    chlorhexidine, preterm, newborn, skin condition, temperature, skin flora

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    60 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Chlorhexidine skin cleansing
    Arm Type
    Experimental
    Arm Description
    Wiping the skin (except the face) once immediately after birth using baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)
    Arm Title
    Saline skin cleansing
    Arm Type
    Placebo Comparator
    Arm Description
    Wiping the skin (except the face) once immediately after birth using baby wipes containing normal saline
    Arm Title
    No skin cleansing
    Arm Type
    No Intervention
    Arm Description
    No skin application
    Intervention Type
    Drug
    Intervention Name(s)
    Chlorhexidine
    Intervention Description
    Baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)
    Intervention Type
    Drug
    Intervention Name(s)
    Normal saline
    Intervention Description
    Cleansing the skin (except the face)with baby wipes containing normal saline
    Primary Outcome Measure Information:
    Title
    Median Skin Condition Score on the 9-point Skin Condition Grading Scale Adapted by Darmstadt From Lane et al
    Description
    The skin condition grading scale assesses the condition of the skin on the abdomen and dorsum of the hands/feet based on drying, erythema, crusting, oozing, etc. on a continuous scale from 1 (normal) to 9 (vesicles or pustules)
    Time Frame
    At 24 hours
    Title
    Skin Temperature at 30 Min After Intervention
    Description
    Axillary skin temperature measured by a clinical thermometer kept in axilla for 3 minutes
    Time Frame
    at 30 min after intervention
    Title
    Number of Participants With Positive Skin Culture at Axilla
    Description
    Occurrence of any bacterial flora irrespective of the colony count in the skin swabs from axilla at 24 hrs after intervention
    Time Frame
    24 hours after intervention
    Secondary Outcome Measure Information:
    Title
    Incidence of Clinical and Culture Positive Sepsis
    Description
    Infants with symptoms and/or signs suggestive of sepsis and a positive blood culture (with known pathogens and coagulase negative staphylococcus) were diagnosed to have culture positive sepsis; Those with negative cultures but with positive sepsis screen were classified as having clinical sepsis
    Time Frame
    First week of life

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    1 Hour
    Maximum Age & Unit of Time
    3 Hours
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Preterm infants of 28 to 36 weeks' gestation Birth weights between 1001 and 2000 g Exclusion Criteria: Infants with one minute Apgar score < 4 Hemodynamic instability Congenital malformations Generalized skin disorder and Infants who need respiratory support (continuous positive airway pressure and/or intermittent mandatory ventilation) in the first 2-3 hours of life
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Mari J Sankar, MD DM
    Organizational Affiliation
    Department of Pediatrics, All India Institute of Medical Sciences, New Delhi
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Vinod K Paul, MD PhD
    Organizational Affiliation
    Department of Pediatrics, All India Institute of Medical Sciences, New Delhi
    Official's Role
    Study Chair
    First Name & Middle Initial & Last Name & Degree
    Ashok K Deorari, MD MNAMS
    Organizational Affiliation
    Department of Pediatrics, All India Institute of Medical Sciences, New Delhi
    Official's Role
    Study Chair
    First Name & Middle Initial & Last Name & Degree
    Gary L Darmstadt, MD MS
    Organizational Affiliation
    Department of International Health, Bloomberg School of Public Health, Johns Hopkins University
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Learn more about this trial

    Safety of Skin Cleansing With Chlorhexidine in Preterm Low Birth Weight Infants

    We'll reach out to this number within 24 hrs